Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas

doi:10.4251/wjgo.v14.i11.2195

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3204)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

153

WORD

HTML

1669

Figures (1-2)

209

Tables (1-3)

216

Sum=2275

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

227

Download

659

Sum=886

Nov 15, 2022 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Oncol. Nov 15, 2022; 14(11): 2195-2207
Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2195

Table 2 Microsatellite instability analysis and CpG island methylator phenotype analysis

	FIT-interval CRC	SD-CRC	P value
MSI analysis^a
MSI	4 (19%)	5 (12%)	0.469
MSS	17 (81%)	36 (88%)
CIMP analysis^b
Methylated, positive	7 (33%)	8 (21%)	0.274
Unmethylated, negative	14 (66%)	31 (79%)

^an = 62.

^bn = 60.

All values expressed as number and % with respect to fecal immunochemical test-interval and screen-detected colorectal cancers. FIT: Fecal immunochemical test; CRC: Colorectal cancer; SD-CRC: Screen-detected colorectal cancer; MSI: Microsatellite instability; MSS: Microsatellite stable; CIMP: CpG island methylator phenotype.

Citation: van der Vlugt M, Carvalho B, Fliers J, Montazeri N, Rausch C, Grobbee EJ, Engeland MV, Spaander MCW, Meijer GA, Dekker E. Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas. World J Gastrointest Oncol 2022; 14(11): 2195-2207
URL: https://www.wjgnet.com/1948-5204/full/v14/i11/2195.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i11.2195